SUBSCRIBE
SUBSCRIBE

Phase 1

Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
10 Biotechs—Count ‘Em, 10!—With Big Decisions in the Fourth Quarter
September 12, 2016
 · 
4 min read
Juno Was Being Wooed to the Big Apple But Here's Why It's Staying in Seattle
Drug Development
Juno Surges as Small Cancer Study is Hailed a Success, Shows Promise for Other Drugs
September 8, 2016
 · 
2 min read
Drug Development
FDA: Toxicity Seen In Fatal French Study Does Not Extend To Other FAAH Inhibitors
August 15, 2016
 · 
1 min read
Boston Scientific Commits to 10 More Years in SoCal Space, Plans to Hire
Drug Development
Vaxart Challenges Takeda with Oral Norovirus Vaccine
August 8, 2016
 · 
3 min read
Why AstraZeneca PLC CEO Took a Job His Friends Called a Suicide Mission
Drug Development
AstraZeneca PLC Kills Six Pipeline Programs
July 28, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
ZIOPHARM Abandons $50 Million Stock Offering After Clinical Trial Deaths
July 15, 2016
 · 
3 min read
How Biogen Makes Most of Its Cash
Drug Development
With Little Fanfare, Biogen Sneaks Lupus Drug Into a Phase I Trial
July 14, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
3 Nauseating Clinical Trial Flops of 2016 So Far
July 11, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Scancell Delays Melanoma Trial 9 to 12 Months to Whip Up New Batch of Cancer Vaccine
July 7, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
This Year’s Top 10 Disappointing Clinical Trials—So Far!
July 5, 2016
 · 
3 min read
Load More
PRESS RELEASES
Press Releases
Bambusa Therapeutics Presents Positive Preliminary Phase 1 BBT002 Data at American Thoracic Society 2026 (ATS 2026) International Conference and Announces First Patient Dosed in Phase 1b/2a CRSwNP Trial
May 18, 2026
 · 
6 min read
Press Releases
Triveni Bio Doses First Healthy Volunteers with Next-Generation Bispecific Antibody TRIV-573 Targeting Kallikreins 5 & 7 and Interleukin 13 in Phase 1 Clinical Trial
May 18, 2026
 · 
3 min read
Press Releases
Earendil Labs Announces First Cohort Dosed in Phase I Study of Novel Biparatopic Antibody Targeting Thymic Stromal Lymphopoietin (TSLP)
May 18, 2026
 · 
2 min read
Press Releases
SEED Therapeutics to Present Phase 1 Trial Design for ST-01156, a First-in-Human Oral RBM39 Molecular Glue Degrader, at 2026 ASCO Annual Meeting
May 18, 2026
 · 
3 min read
Press Releases
Design Therapeutics Announces Four-Week IV Data from the RESTORE-FA Trial of DT-216P2 Demonstrating Clinical Improvements and Comprehensive Biomarker Activity in Friedreich Ataxia
May 18, 2026
 · 
8 min read
Press Releases
Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
May 18, 2026
 · 
4 min read
Press Releases
Prokarium Reports Positive Interim Data from Phase 1/1b PARADIGM-1 trial of ZH9 in NMIBC patients, Demonstrating Excellent Safety and Encouraging Early Efficacy
May 18, 2026
 · 
2 min read
Press Releases
Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich’s Ataxia on Monday, May 18, 2026
May 17, 2026
 · 
1 min read
Press Releases
Agenus Announces Publication of Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Hepatocellular Carcinoma in Liver Cancer
May 17, 2026
 · 
9 min read
Press Releases
Atisama Therapeutics Advances RB042 into Multiple Ascending Dose cohorts of Phase 1 Trial and Appoints Bernard Coulie as Chair of the Board
May 17, 2026
 · 
4 min read
Press Releases
Positive Interim Data from Cohorts 1 and 2 of Tenaya’s RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Demonstrated Consistent Reductions in Arrhythmia Burden for Adults with PKP2-associated ARVC
May 15, 2026
 · 
13 min read
Press Releases
SN BioScience Doses First Patient in Phase 1b/2 Clinical Trial of ‘SNB-101'
May 14, 2026
 · 
2 min read
Press Releases
Nurix Therapeutics Presents New Preclinical and Phase 1 Translational Data Supporting Bexobrutideg (NX-5948) in Chronic Spontaneous Urticaria at the 2026 Society for Investigative Dermatology Annual Meeting
May 14, 2026
 · 
7 min read
Press Releases
Imviva Biotech Presents Data Demonstrating Durable Clinical Responses from Ongoing Phase 1/2 Study of CTA313 in Systemic Lupus Erythematosus at ASGCT 2026
May 14, 2026
 · 
3 min read
Press Releases
Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program
May 14, 2026
 · 
11 min read
Press Releases
MIRA Pharmaceuticals Reports Positive Unblinded Phase 1 Data for Ketamir-2
May 14, 2026
 · 
6 min read
Press Releases
Forward Therapeutics Announces Completion of Phase 1 Trials with Two Internally Discovered Next-Generation TNF Signaling Inhibitors Supporting Advancement to Phase 2 Clinical Development
May 14, 2026
 · 
3 min read
Press Releases
Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting
May 14, 2026
 · 
18 min read
Press Releases
Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress
May 14, 2026
 · 
5 min read
Press Releases
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026
 · 
11 min read
Load More